The largest database of trusted experimental protocols

14 protocols using psp72

1

Gene Disruption and Complementation in Magnaporthe oryzae

Check if the same lab product or an alternative is used in the 5 most similar protocols
Deletion mutants of Rhm1, Ddnm1, MoRad55, MoRad57, and their double deletion mutants were constructed through targeted gene disruption by HR. The gene disruction vector used was either pSP72-HPH32 (link), which carries a 1.4 kb hygromycin-resistance gene cassette between the SalI and BamHI sites in pSP72 (Promega), or pII9933 (link), which carries a geneticin-resistance gene cassette. The 5′ and 3′ flanking fragments of the target gene were amplified by PCR using sets of specific primers (Supplementary Data 1). The amplified fragments were inserted at appropriate sites in either pSP72-HPH or pII99 to establish disruption vectors. The disruption vectors were then introduced into the Br48 strain through PEG-mediated transformation. The resulting P. oryzae transformants were screening initially by PCR, and then by Southern blots analysis to confirm a HR event in them (Supplementary Figs. 2, 7).
For gene complementation experiments, a 9.2 kb DNA fragment containing the MGG_15576 and MGG_15577 loci was first PCR-amplified by the high fidelity DNA polymerase, KOD-Plus (Toyobo) with a set of primers (Supplementary Data 1) and cloned into the NotI site in pBluescript SK(-) (Stratagene) to establish pBS-MoRad51. pBS-MoRad51 was introduced into the ΔMGG_11350-22 strain by co-transformation with pII99 (pre-complementaion) or pMGY-ΔRT-G (co-complementation).
+ Open protocol
+ Expand
2

Construction of Multiplex qPCR Standard

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four gene fragments of PCV2, PCV3, PPV, and PRV, generated by PCR using their respective genomes as templates, were simultaneously inserted into a cloning vector of pSP72 (Promega) in tandem and served as a standard plasmid (pSP72-PCV2 cap & PCV3 cap & PPV NS1 & PRV gE) in subsequent assays (Figure 2A). Briefly, the four gene fragments were digested with XhoI/HindIII, HindIII/BamHI, BamHI/KpnI, and KpnI/SacI(Thermo Fisher Scientific), and then purified and ligated to the vector digested with XhoI/ SacI. Finally, the ligation products were transformed into Escherichia coli DH5α competent cells (TransGen). The positive clones were cultured at 37°C for 20 h then extracted by Plasmid DNA Mini Kit (Omega) and confirmed by DNA sequencing. The resulting plasmids were quantified by ultraviolet absorbance at 260 nm and 280 nm using a NanoDrop spectrophotometer (Thermo Fisher, USA). According to the size of the standard plasmid template, the copy numbers of the purified plasmids were calculated based on the following formula: (A260 (ng/μL) × 10−9 × 6.02 × 1023) / (DNA length×650) = copies/μL. Then, 10-fold serial dilutions of the standard plasmid, with the same starting concentration of 109 copies/μL, were performed to generate four standard curves for testing the multiplex real-time PCR.
+ Open protocol
+ Expand
3

Conditional Cre-ERT2 Gene Targeting

Check if the same lab product or an alternative is used in the 5 most similar protocols
The FRT-Neo-FRT-loxP cassette from the FRT-PGK-gb2-neo-FRT-loxP plasmid (GeneBridges) was cloned downstream of the CreERT2 complementary DNA (cDNA) in pBluescript by standard restriction-ligation methods. The ~10.12-kb region used to construct the targeting vector was first subcloned from a C57BL/6 BAC (bacterial artificial chromosome) clone (RPCI23:33N14) into pSP72 (Promega) using homologous recombination. The Cre-ERT2-FRT-Neo-FRT-LoxP cassette was then inserted into exon 1 just downstream of the endogenous ATG site, replacing 1864 base pairs of the coding region spanning exons 1 and 2. The short homology arm extends 2.22 kb downstream of the 3′ end of the FRT-Neo-FRT-LoxP cassette. The long homology arm ends immediately 5′ of the Cre-ERT2 gene and measures ~6.03 kb (fig. S8).
+ Open protocol
+ Expand
4

Targeting Vector Construction for Exon 12 Mutation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A ~8.49 kb region used to construct the targeting vector was sub-cloned from a positively identified C57BL/6 BAC clone (RP23: 83F10). The region was designed such that the long homology arm (LA) extends ~6.11 kb 5′ to the site of the point mutations (G>A) in exon 12 and the FRT-LoxP-flanked Neo cassette is inserted 462 bp 3′ to the point mutation. The short homology arm (SA) extends 1.91 kb 3′ to the FRT-LoxP-flanked Neo cassette. The targeting vector was constructed using Red/ET recombineering technology. The BAC was sub-cloned into a ~2.4 kb backbone vector (pSP72, Promega, Madison, WI, USA) containing an ampicillin selection cassette for re-transformation of the construct prior to electroporation. A pGK-gb2 FRT-LoxP Neo cassette was inserted into the gene as described in the project schematic (Supplementary Figure 1a). The targeting construct can be linearized using NotI prior to electroporation into embryonic stem (ES) cells. The total size of the targeting construct (including vector backbone and Neo cassette) is 14.21 kb. The schematic representation of the targeting vector is shown in Supplementary Figure 1a.
+ Open protocol
+ Expand
5

In situ Hybridization of Enhancer Regions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Embryos were collected and subjected to in situ hybridization as described previously [12 (link)]. Enhancer regions were cloned in vector pSP72 (Promega), then digested with appropriate enzymes to make labeled run-off transcripts using T7 or SP6 RNA transcriptase, with the DIG RNA labeling kit (Roche Applied Science). The two probes produced by T7 or SP6 recognize the same enhancer region, but different strands. The genomic regions used for probes are listed in S10 Fig. In order to reduce staining variability when lines were to be compared, in situ hybridization was performed in parallel at the same time. Representative embryos from the stained populations are shown.
+ Open protocol
+ Expand
6

Generation of Adrbk1 S670A Knock-in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Ser670→Ala670 (S670A) mutation was generated in the Adrbk1 gene located in exon 21. A ~9.86-kb region used to construct the targeting vector was first subcloned from a positively identified C57BL/6 bacterial artificial chromosome (BAC) clone (RP23: 28A2). The region was designed such that the long homology arm extends ~5.88 kb 3′ to the site of the point mutations (T→G) in exon 21 and the FRT-flanked Neo cassette is inserted 1.74 base pair (bp) 5′ to the point mutations. The short homology arm extends 2.24 kb 5′ to the FRT-flanked Neo cassette. The targeting vector was constructed using Red/ET recombineering technology. The BAC was subcloned into a ~2.4-kb backbone vector (pSP72, Promega) containing an ampicillin selection cassette for retransformation of the construct before electroporation. A pGK-gb2 FRT Neo cassette was inserted into the gene. The targeting construct was linearized using Not I before electroporation into embryonic stem cells. Positive clones were injected to generate chimeric mice and GRK2-S670A mice (inGenious Targeting Laboratory). Mutation was confirmed by polymerase chain reaction products flanking exon 21. Screening was performed using the primers 5′-GGGTGTGTCACAGTTGGAACC-3′ and 5′-GGGCTCTGCACCATTCAAGTTGAG-3′.
+ Open protocol
+ Expand
7

Protein Expression Assay for Hint1 and Caren

Check if the same lab product or an alternative is used in the 5 most similar protocols
An in vitro translation assay was performed using a Human Cell-Free Protein Expression System (Takara Bio Inc), according to the manufacturer’s instructions. In brief, cDNA encoding C-terminally HA-tagged murine Hint1 was cloned into the pUC-T7-IRES vector (Takara Bio Inc), and Caren, antisense Caren, and Caren fragment A–E cDNAs were cloned into pSP72 (Promega, Madison, WI, USA). The plasmid encoding Hint1 and either the pSP72 vector or plasmids encoding Caren, antisense Caren or one of Caren fragments A–E were incubated with T7 RNA polymerase in human cell lysates at 37 °C for 2 h. Samples were then subjected to western blotting analysis. In some experiments, in vitro-transcribed Caren was incubated at 94 °C for 2 min and snap-cooled on ice for denaturation66 (link). Plasmids encoding Hint1 plus either native or denatured Caren were incubated with T7 RNA polymerase in human cell lysates at 37 °C for 2 h and then subjected to western blotting analysis.
+ Open protocol
+ Expand
8

CaMKII Isoform Overexpression in H9C2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The catalytically inactive form (rCaMKIIalpha, K42M, impaired ATP binding pocket, (CaMKII DN)) and the wild type (CaMKII-WT, rCaMKIIalpha) variant of CaMKII were subcloned into pSP72 (Promega). Adenoviruses encoding CaMKII catalytically inactive (CaMKII-DN) and wild type (CaMKII-WT) were generated using the AdEasy system (Quantum Biotechnologies) [32 (link)–34 (link)].
H9C2 cells at ≈ 70% confluence were incubated 1 h at 37°C with 5 mL DMEM containing purified adenovirus at a multiplicity of infection (moi) of 100:1, encoding either the CaMKII-DN, CaMKII-WT variants I or the empty virus as a negative control (Ctr) [16 (link)]. 24 h after the infection, the cells were used for the experiments. Transient transfection of the PKA-I plasmid was performed using Lipofectamine 2000 (Invitrogen) in 70% confluent H9C2s.
+ Open protocol
+ Expand
9

Conditional Deletion of Adamts9 Allele

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Adamts9 allele was engineered using a 10.68 kb region subcloned from a C57BL/6 BAC clone (RP23:379C7) by flanking exons 5–8 with unidirectional loxP sites. A loxP site is also located adjacent to the FRT flanked cassette for neomycin resistance (Neo) (from pGK-gb2 LoxP/FRT Neo) inserted 299 bp upstream of exon 5 (Fig. 1a). The short 5´ homology arm extended 1.76 kb upstream of the selection cassette, whereas the longer 3´ homology arm extended 6.86 kb downstream of exon 8. The region targeted for deletion by Cre-recombinase (exons 5–8) is 2.06 kb. The targeting vector underwent restriction mapping and nucleotide sequencing after each modification step, i.e., to read into the 5´ and 3´ ends of the construct, to verify the 5´ and 3´ ends of the LoxP/FRT Neo cassette and to sequence the homology arms, respectively. The engineered BAC was cloned into a ~2.4kb backbone vector (pSP72, Promega Corp, Madison, WI) containing an ampicillin selection cassette for amplification of the construct prior to electroporation. The total size of the targeting construct (including vector backbone) was 14.78 kb.
+ Open protocol
+ Expand
10

Molecular Analysis of Bat NPC1 Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from FBKT1, ZFBK13-76E, ZFBK11-97, ZFBK15-137RA, DemKT1, SuBK12-08, YubFKT1, and BKT1 cells using ISOGEN (Nippongene) and mRNAs were reverse transcribed with Superscript IV (Invitrogen). To amplify NPC1 genes of FBKT1 and ZFBK13-76E, polymerase chain reaction (PCR) was performed with KOD-Plus Neo (TOYOBO) using primer sets designed based on the sequences of P. vampyrus (GenBank : XM_023530841.1) and Miniopterus natalensis bats (GenBank: XM_016211523.1). PCR products were directly sequenced or cloned into TOPO (Invitrogen) or pSP72 (Promega) plasmid vectors followed by sequencing. After sequence confirmation, wild-type and mutant NPC1 genes of HEK293T, FBKT1, and ZFBK13-76E were inserted into the pMXs-puro retroviral vector (Cell Biolabs). The plasmids of mutant NPC1 genes were constructed by site-directed mutagenesis with KOD-Plus Neo. After sequence confirmation, these mutant genes were inserted into the retroviral vector. An In-Fusion cloning kit (BD Clontech) was used for constructing the retroviral vectors carrying NPC1 genes.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!